INFUSYSTEM HOLDINGS, INC

INFU ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $67.1M $71.1M $70.5M $70.5M $66.5M $62.3M $58.8M $54.6M
Cost of Revenue $27.6M $18.4M $16.2M $13.8M $12.2M $11.3M $9.2M $9.1M
Gross Profit $39.6M $43.4M $44.7M $49.6M $47.4M $43.7M $42.9M $35.4M
Gross Margin 58.9% 61.0% 63.5% 70.3% 71.2% 70.1% 72.9% 64.7%
Operating Expenses
Research & Development
SG&A Expense $25.4M $25.2M $24.6M $23.8M $20.0M $19.0M $23.1M $18.0M
Operating Income $415.0K $-3.8M $974.0K $7.3M $9.3M $5.9M $2.0M $-66.4M
Operating Margin 0.6% -5.4% 1.4% 10.3% 14.0% 9.5% 3.4% -121.4%
Interest Expense $1.4M $1.3M $1.3M $1.7M $3.1M $3.5M $3.3M $2.2M
Pretax Income $-1.0M $-5.3M $-364.0K $4.0M $6.2M $2.7M $-2.2M $-68.6M
Income Tax Expense $53.0K $15.5M $-142.0K $1.2M $2.9M $1.0M $-663.0K $-23.1M
Net Income $-1.1M $-20.7M $-222.0K $2.8M $3.4M $1.7M $-1.5M $-45.4M
Net Margin -1.6% -29.1% -0.3% 3.9% 5.0% 2.7% -2.5% -83.2%
EPS (Basic) $-0.05 $-0.91 $-0.01 $0.13 $0.15 $0.08 $-0.07 $-2.16
EPS (Diluted) $-0.05 $-0.91 $-0.01 $0.12 $0.15 $0.08 $-0.07 $-2.16
Shares Outstanding (Basic) 21.4M 22.7M 22.6M 22.4M 22.2M 21.9M 21.4M 21.1M
Shares Outstanding (Diluted) 21.4M 22.7M 22.6M 22.8M 22.6M 22.1M 21.4M 21.1M
Dividends Per Share
← Newer Page 2 of 3 Older →